The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls
Abstract
INTRODUCTION: Adenoviruses (Ads) have attracted researchers from across the disciplines for several reasons. Their ability to recombine with and express the heterologous genes encouraged their development as gene/vaccine delivery vectors. Preclinical and clinical trials using these vectors have shown significant promise for their future development while highlighting certain limitations. AREAS COVERED: Ad vector development, clinical application of these vectors in gene therapy and vaccine development, and promises that these vectors offered for future development are discussed. Also, various factors affecting their in vivo efficacy as well as the strategies being pursued to overcome these obstacles are described. EXPERT OPINION: Decades of efforts have resulted in understanding various aspects of human Ad 5 biology as well as the in vivo behavior of vectors derived from this serotype. While this vector has shown great potential, some of the limitations highlighted in recent studies have reinforced the quest for an ideal vector derived from novel Ads. Combinatorial approaches to address the various limitations of the existing vectors must be pursued to develop novel vectors with enhanced clinical potential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adenoviruses (Ad) are non-enveloped, double-stranded DNA viruses with a packaging ability of 30 to 40 kb DNA [54].”
From The Ocular Gene Delivery Landscape (2021) · cites this paper as [54]
Citations
Cites
Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., Gilbert, P. B., Lama, J. R., Marmor, M., del Rio, C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61591-3 · Cited by 1,713
Raper, S. E., Chirmule, N. B., Lee, F. S., Wivel, N. A., Bagg, A., Gao, G., Wilson, J. M., & Batshaw, M. L. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.016 · Cited by 1,531
Adenoviruses: update on structure and function
Russell, W. C. (2008) · Journal of General Virology · doi:10.1099/vir.0.003087-0 · Cited by 462
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Barnes, E. J., Folgori, A., Capone, S., Swadling, L., Aston, S., Kurioka, A., Meyer, J., Huddart, R., Smith, K., Townsend, R., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003155 · Cited by 404
Barouch, D. H., Kik, S. V., Weverling, G. J., Dilan, R., King, S. L., Maxfield, L. F., Clark, S., Ng’ang’a, D., Brandariz, K., Abbink, P., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.025 · Cited by 305
Virus-mediated gene delivery for human gene therapy
Giacca, M., & Zacchigna, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.008 · Cited by 302
Parker, A. L., Waddington, S. N., Nicol, C. G., Shayakhmetov, D. M., Buckley, S. M. K., Denby, L., Kemball‐Cook, G., Ni, S., Lieber, A., McVey, J. H., et al. (2006) · Blood · doi:10.1182/blood-2006-04-008532 · Cited by 297
Mast, T. C., Kierstead, L. S., Gupta, S. B., Nikas, A. A., Kallas, E. G., Novitsky, V., Mbewe, B., Pitisuttithum, P., Schechter, M., Vardas, E., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.145 · Cited by 283
Zhang, Y., & Bergelson, J. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12125-12131.2005 · Cited by 262
Vacchelli, E., Eggermont, A. M. M., Sautès‐Fridman, C., Galon, J., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2013) · OncoImmunology · doi:10.4161/onci.24612 · Cited by 260
Research works printed but not linked: 2
- Hemminki A, 2014, Scientifica (Cairo), 2014, 862925
- Harris JD, 2009, In Vivo, 23, 885
Cited by
Sorted by citations
Gene Therapy Leaves a Vicious Cycle
Goswami, R., Subramanian, G., Silayeva, L., Newkirk, I., Doctor, D. M., Chawla, K., Chattopadhyay, S., Chandra, D., Chilukuri, N., & Betapudi, V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00297 · Cited by 366
Viral vector‐based gene therapies in the clinic
Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10258 · Cited by 269
Oral vaccination of fish: Lessons from humans and veterinary species
Embregts, C. W. E., & Forlenza, M. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.03.024 · Cited by 178
Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair
Cucchiarini, M., & Madry, H. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0125-2 · Cited by 133
Gene therapy and genome surgery in the retina
DiCarlo, J. E., Mahajan, V. B., & Tsang, S. H. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120429 · Cited by 127
Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5–based Constructs
Alonso-Padilla, J., Papp, T., Kaján, G. L., Benkő, M., Havenga, M. J. E., Lemckert, A. A. C., Harrach, B., & Baker, A. H. (2015) · Molecular Therapy · doi:10.1038/mt.2015.194 · Cited by 105
Maler, M. D., Nielsen, P. J., Stichling, N., Cohen, I., Ruzsics, Z., Wood, C., Engelhard, P., Suomalainen, M., Győry, I., Huber, M., et al. (2017) · mBio · doi:10.1128/mbio.00670-17 · Cited by 77
microRNA inhibitors: Natural and artificial sequestration of microRNA
Tang, L., Chen, H., Hao, N.-B., Tang, B., Guo, H., Yong, X., Dong, H. F., & Yang, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.025 · Cited by 74
Atomic Structures of Minor Proteins VI and VII in Human Adenovirus
Dai, X., Wu, L., Sun, R., & Zhou, Z. H. (2017) · Journal of Virology · doi:10.1128/jvi.00850-17 · Cited by 70
M cell targeting engineered biomaterials for effective vaccination
Islam, M. A., Firdous, J., Badruddoza, A. Z. M., Reesor, E., Azad, M. A., Hasan, A., Lim, M., Cao, W., Guillemette, S. R., & Cho, C. S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.041 · Cited by 64
Omoteso, O. A., Fadaka, A. O., Walker, R. B., & Khamanga, S. M. (2025) · Microorganisms · doi:10.3390/microorganisms13040722 · Cited by 65
Adenovirus vectors in hematopoietic stem cell genome editing
Li, C., & Lieber, A. (2019) · FEBS Letters · doi:10.1002/1873-3468.13668 · Cited by 53
Adenovirus entry: Stability, uncoating, and nuclear import
Greber, U. F., & Suomalainen, M. (2022) · Molecular Microbiology · doi:10.1111/mmi.14909 · Cited by 50
Stepanenko, A. A., & Chekhonin, V. P. (2018) · Virus Research · doi:10.1016/j.virusres.2018.08.012 · Cited by 49
Poly‐Adenine‐Based Spherical Nucleic Acids for Efficient Live‐Cell MicroRNA Capture
Jiao, K., Yan, Q., Guo, L., Qu, Z., Cao, S., Chen, X., Li, Q., Zhu, Y. J., Li, J., Wang, L., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202017039 · Cited by 47
Shock wave-induced permeabilization of mammalian cells
Lopez-Marin, L. M., Rivera, A. L., Fernández, F., & Loske, A. M. (2018) · Physics of Life Reviews · doi:10.1016/j.plrev.2018.03.001 · Cited by 49
Recent advances in carbon quantum dots for gene delivery: A comprehensive review
Othman, H. O., Anwer, E. T., Ali, D. S., Hassan, R. O., Mahmood, E. E., Ahmed, R. A., Muhammad, R. F., & Smaoui, S. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31236 · Cited by 49
LeClair, D. A., Cranston, E. D., Xing, Z., & Thompson, M. R. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.067 · Cited by 46
Evans, C. H., Ghivizzani, S. C., & Robbins, P. D. (2021) · JBJS Reviews · doi:10.2106/jbjs.rvw.20.00220 · Cited by 42
Middle East respiratory syndrome: obstacles and prospects for vaccine development
Papaneri, A. B., Johnson, R. F., Wada, J., Bollinger, L., Jahrling, P. B., & Kuhn, J. H. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1036033 · Cited by 34
Progress on adenovirus-vectored universal influenza vaccines
Xiang, K., Guan, Y., Yan, Z., Shanshan, Y., Zhang, L., Li, H., & Maosheng, S. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1016674 · Cited by 34
Morgan, B. A., Manser, M., Jeyanathan, M., Xing, Z., Cranston, E. D., & Thompson, M. R. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00317 · Cited by 30
The Ocular Gene Delivery Landscape
Sahu, B., Chug, I., & Khanna, H. (2021) · Biomolecules · doi:10.3390/biom11081135 · Cited by 28
Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair
Madrigal, J. L., Stilhano, R. S., & Silva, E. A. (2017) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2016.0462 · Cited by 28
Pérez-Illana, M., Martínez, M., Condezo, G. N., Hernando‐Pérez, M., Mangroo, C., Brown, M., Marabini, R., & Martı́n, C. S. (2021) · Science Advances · doi:10.1126/sciadv.abd9421 · Cited by 28
Current Trends in Viral Gene Therapy for Human Orthopaedic Regenerative Medicine
Venkatesan, J. K., Rey‐Rico, A., & Cucchiarini, M. (2019) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-019-00179-x · Cited by 28
Fonseca, J. A., McCaffery, J. N., Caceres, J., Kashentseva, E. A., Singh, B., Dmitriev, I. P., Curiel, D. T., & Moreno, A. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.03.091 · Cited by 27
Zhang, H., Liu, C., Zhang, F.-F., Geng, F., Qiu, X., Lu, Z.-Z., Xu, P., Xie, Y., Wu, H., Yu, B., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.04.045 · Cited by 27
Current Status of Poultry Recombinant Virus Vector Vaccine Development
Wang, H., Tian, J., Zhao, Y., Zhao, Y., Yang, H., & Zhang, G. (2024) · Vaccines · doi:10.3390/vaccines12060630 · Cited by 26
Lee, C., Lin, C.-L., Leu, S., & Lee, Y. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.10.005 · Cited by 25
Wang, J., & Zhang, L. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104829 · Cited by 25
Interleukin-12-expressing oncolytic virus: A promising strategy for cancer immunotherapy
Alkayyal, A. A., Mahmoud, A. B., & Auer, R. C. (2016) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2016.04.002 · Cited by 22
Liu, X., Zhao, D., Zhou, P., Zhang, Y., & Wang, Y. (2019) · BioMed Research International · doi:10.1155/2019/8530273 · Cited by 22
Applications of Gene Editing and Nanotechnology in Stem Cell-Based Therapies for Human Diseases
Bolideei, M., Barzigar, R., Gahrouei, R. B., Mohebbi, E., Haider, K. H., Paul, S., Paul, M. K., & Mehran, M. J. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10857-0 · Cited by 22
Biology of Adenovirus Cell Entry
Luisoni, S., & Greber, U. F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800276-6.00002-4 · Cited by 22
Stepanenko, A. A., & Chekhonin, V. P. (2018) · Gene · doi:10.1016/j.gene.2018.08.069 · Cited by 21
Oncolytic virus preclinical toxicology studies
Rasa, A., & Alberts, P. (2022) · Journal of Applied Toxicology · doi:10.1002/jat.4408 · Cited by 20
Rashid, I., Moiré, N., Héraut, B., Dimier‐Poisson, I., & Mévélec, M.-N. (2016) · Medical Microbiology and Immunology · doi:10.1007/s00430-016-0483-9 · Cited by 20
Kim, S.-Y., Lee, S.-J., Han, H., & Lim, S. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.045 · Cited by 20
Tian, X., Qiu, H., Zhou, Z., Wang, S., Fan, Y., Li, X., Chu, R., Li, H., Zhou, R., & Wang, H. (2017) · Journal of Virology · doi:10.1128/jvi.01643-17 · Cited by 18
Viral Vectors, Engineered Cells and the CRISPR Revolution
DiCarlo, J. E., Deeconda, A., & Tsang, S. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-63904-8_1 · Cited by 19
Will Nanotechnology Bring New Hope for Stem Cell Therapy?
Farzamfar, S., Nazeri, N., Salehi, M., Valizadeh, Ř., Marashi, S. M., Kouzehkonan, G. S., & Ghanbari, H. (2018) · Cells Tissues Organs · doi:10.1159/000500517 · Cited by 18
Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon
Su, X., Tian, X., Jiang, Z., Ma, Q., Liu, Q., Lu, X., & Zhou, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156984 · Cited by 17
van Tricht, E., Geurink, L., Garre, F. G., Schenning, M., Backus, H. H. J., Germano, M., Somsen, G. W., & van de Griend, C. S. (2019) · Electrophoresis · doi:10.1002/elps.201900068 · Cited by 17
Liu, G., Li, Z., Li, Q., Jin, Y., Zhu, Y., Wang, Y., Liu, M., Li, Y., & Li, Y. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.07.005 · Cited by 17
Nanotechnology in stem cell research and therapy
Bharti, S., Anant, P. S., & Kumar, A. (2022) · Journal of Nanoparticle Research · doi:10.1007/s11051-022-05654-6 · Cited by 18
Molecular signatures for vaccine development
Maertzdorf, J., Kaufmann, S. H. E., & Weiner, J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.075 · Cited by 14
Yang, X., Ren, L., Lü, Y., Deng, C.-Y., & Li, F. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0463 · Cited by 14
Zhang, J., Wang, D., Hu, N., Wang, Q., Yu, S., & Wang, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4405-z · Cited by 13
Carlo, F. D., Thomas, L., Brooke, B., Varney, E. T., Nande, R. P., Boskovic, O., Marshall, G. D., Claudio, P. P., & Howard, C. M. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1771-0 · Cited by 13
Silk fibroin scaffolds loaded with angiogenic genes in adenovirus vectors for tissue regeneration
Wang, W., Yu, Y., Jiang, Y., Qu, J., Niu, L., Yang, J., & Li, M. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2819 · Cited by 13
Matteson, N. L., Barry, M. A., & Reddy, V. S. (2018) · Virology · doi:10.1016/j.virol.2018.01.007 · Cited by 12
Wild, S. L., & Tosh, D. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200219 · Cited by 11
Li, B., Sun, S., Li, M., Cheng, X., Li, H., Kang, F., Kang, J., Dörnbrack, K., Nassal, M., & Sun, D. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.08.007 · Cited by 11
The State of the Art of Investigational and Approved Nanomedicine Products for Nucleic Acid Delivery
Paredes, K. O., Ruíz-Cabello, J., Alarcón, D. I., & Filice, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814470-1.00015-0 · Cited by 11
Chuang, H., Chang, J., Fan, Y.-Y., Hsieh, C., & Lee, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117738 · Cited by 9
Deng, G., Li, W., Wu, X., Bao, S., Zeng, J., Zhao, N., Luo, M., Liu, X., & Wang, Y. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.10.016 · Cited by 9
Yang, X., Wang, H., Lu, W.-L., Ma, W., Zhang, H., & Li, F. (2020) · PubMed Central · Cited by 8
Kim, S., Lee, M.-K., & Lim, S. (2016) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0261-0 · Cited by 8
Luchicchi, A., Pattij, T., Viaña, J. N. M., de Kloet, S. F., & Marchant, N. J. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.109004 · Cited by 8
The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
Mata‐Espinosa, D., Lara-Espinosa, J. V., Barrios‐Payán, J., & Hernández‐Pando, R. (2023) · Pharmaceuticals · doi:10.3390/ph16101475 · Cited by 8
Long Non-Coding RNAs in Cardiac Hypertrophy
Mangraviti, N., & Windt, L. J. D. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.836418 · Cited by 7
van Tricht, E., de Raadt, P., Verwilligen, A., Schenning, M., Backus, H. H. J., Germano, M., Somsen, G. W., & van de Griend, C. S. (2018) · Journal of Chromatography A · doi:10.1016/j.chroma.2018.10.045 · Cited by 7
Bioengineering strategies for gene delivery
Shams, S., & Silva, E. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816221-7.00004-5 · Cited by 8
Immunogenicity of Different Forms of Middle East Respiratory Syndrome S Glycoprotein
Ozharovskaia, T. A., Zubkova, O. V., Dolzhikova, I. V., Gromova, A. S., Grousova, D. M., Ильдарович, Т. А., Popova, O. D., Shcheblyakov, D. V., Scherbinin, D. N., Dzharullaeva, A. S., et al. (2019) · Acta Naturae · doi:10.32607/20758251-2019-11-1-38-47 · Cited by 6
Development and characterization of a vector system based on the simian adenovirus type 25
Ozharovskaia, T. A., Popova, O. D., Zubkova, O. V., Викторовна, В. И., Pochtovyy, A., Shcheblyakov, D. V., Gushchin, V. А., Logunov, D., & Al, G. (2023) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2023.006 · Cited by 6
Dose Effects of Recombinant Adenovirus Immunization in Rodents
Weaver, E. A. (2019) · Vaccines · doi:10.3390/vaccines7040144 · Cited by 6
Cai, X., Zhang, X., & Bai, H. (2020) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/ypgx4 · Cited by 6
Valliyott, L., Dungdung, R., & Pilankatta, R. (2019) · Analytical Biochemistry · doi:10.1016/j.ab.2019.113568 · Cited by 5
Activation of OX40 and CD27 Costimulatory Signalling in Sheep through Recombinant Ovine Ligands
Rojas, J. M., Alejo, A., Avia, M., Rodríguez-Martín, D., Sánchez, C., Alcamı́, A., Sevilla, N., & Martı́n, V. (2020) · Vaccines · doi:10.3390/vaccines8020333 · Cited by 5
Haut, L. H., Gill, A. L., Kurupati, R. K., Bian, A., Li, Y., Giles‐Davis, W., Xiang, Z., Zhou, X., & Ertl, H. C. J. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2016.044 · Cited by 5
rAAV9-UPII-TK-EGFP can precisely transduce a suicide gene and inhibit the growth of bladder tumors
Lian, F., Ye, Q., Feng, B. C., Cheng, H., Niu, S., Fan, N., Wang, D., & Wang, Z. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1844115 · Cited by 4
Scavenger Receptors in the Pathogenesis of Viral Infections
Fierro, N. A., Rivera-Toledo, E., Ávila-Horta, F., Anaya-Covarrubias, J. Y., & Mendlovic, F. (2022) · Viral Immunology · doi:10.1089/vim.2021.0167 · Cited by 6
Razrabotka i harakteristika vektornoj sistemy na osnove adenovirusa obez'yan 25-go serotipa
Ozharovskaia, T. A., Попова, О., Zubkova, O. V., Викторовна, В. И., Pochtovyy, A. A., Щебляков, Д. В., Алексеевич, Г. В., Логунов, Д. Ю., & Al, G. (2023) · Вестник Российского государственного медицинского университета · doi:10.24075/vrgmu.2023.006 · Cited by 4
Wang, D., Zhao, M., Liu, Y.-Q., Liu, X.-W., Niu, H., Song, Y., & Tian, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12324 · Cited by 4
Gene Therapy in Skin and Wound Healing
Nuutila, K., Singh, M., & Eriksson, E. K. (2018) · Springer eBooks · doi:10.1007/978-3-319-78957-6_2 · Cited by 4
Heiniö, C., Sorsa, S., Siurala, M., Grönberg-Vähä-Koskela, S. A. M., Havunen, R., Haavisto, E., Koski, A., Hemminki, O., Zafar, S., Cervera-Carrascón, V., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.240 · Cited by 4
Hitching a Ride: Enhancing Nucleic Acid Delivery into Target Cells Through Nanoparticles
Penumarthi, A., Basak, P., Smooker, P. M., & Shukla, R. (2020) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-29207-2_11 · Cited by 4
Poly‐Adenine‐Based Spherical Nucleic Acids for Efficient Live‐Cell MicroRNA Capture
Jiao, K., Yan, Q., Guo, L., Qu, Z., Cao, S., Chen, X., Li, Q., Zhu, Y. J., Li, J., Wang, L., et al. (2021) · Angewandte Chemie · doi:10.1002/ange.202017039 · Cited by 3
A Critical Assessment of COVID-19 Genomic Vaccines
Sabbah, D. A., Hajjo, R., & Sunoqrot, S. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230825094341 · Cited by 4
Replication-Competent Viral Vectors for Vaccine Delivery
Parks, C. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802302-0.00001-7 · Cited by 3
Tsitoura, E., Kazazi, D., Arslan, D. Ö., Sever, E. A., Khalili, S., Vassilaki, N., Aslanoglou, E., Dérian, N., Six, A., Sezerman, O. U., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.161 · Cited by 2
Turner, A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803942-7.00014-3 · Cited by 2
Viral-vectored vaccines against SARS-CoV-2
Kim, Y. C., & Reyes‐Sandoval, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90248-9.00003-6 · Cited by 2
Ayalew, L. E., Gaba, A., Wang, W., & Tikoo, S. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-51927-8_5 · Cited by 2
Hidalgo, P., & González, R. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00066-5 · Cited by 2
Liu, Y., Li, W., Li, G., Li, X., Cao, H., Wang, Y., & Zheng, S. J. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108460 · Cited by 1
Diagnosis and Assessment of Microbial Infections with Host and Microbial microRNA Profiles
Cui, L., Stratton, C. W., & Tang, Y. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3970-7_46 · Cited by 1
Hydrogels as biologics/gene delivery systems
Rey‐Rico, A., Carballo-Pedrares, N., Venkatesan, J. K., Madry, H., & Cucchiarini, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823948-3.00034-8 · Cited by 1
Ying-Fen, L., Chun, S., Jun, Y., Shuai-Bo, H., Chen, Y., Gui-lan, W., KaiGong, W., Shan, C., Er-Peng, Z., & Cheng, Z. (2025) · Poultry Science · doi:10.1016/j.psj.2025.105185 · Cited by 1
Viruses and the Evolution of Viral Vectors
Giles, C., & Vanniasinkam, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-51927-8_3 · Cited by 1
Preparation of Lipid–Peptide–DNA (LPD) Nanoparticles and Their Use for Gene Transfection
Zhang, F., & Li, H. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0319-2_6 · Cited by 1
Diagnosis and Assessment of Microbial Infections with Host and Microbial MicroRNA Profiles
Cui, L., Markou, A. N., Stratton, C. W., & Lianidou, E. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-95111-9_23 · Cited by 1
Kuznetsova, N. A., Gushchin, V. А., Marchuk, E. V., Siniavin, A. E., Kleymenov, D. A., Nikiforova, M. A., Zubkova, O. V., Popova, O., Викторовна, В. И., Ozharovskaia, T. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.16.633390 · Cited by 1
Adenovirus-host interactions : implications for tropism and therapy
Lenman, A. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Alkayyal, A. A. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-557
Emerging Considerations in Virus-Based Gene Transfer Systems
Condreay, J. P., Kost, T. A., & Mickelson, C. A. (2016) · ASM Press eBooks · doi:10.1128/9781555819637.ch10
Capsid protein functions of enteric human adenoviruses
Rajan, A. (2018) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Gene Therapy Approaches for Cochlear Repair
Richardson, R. T., & Gunewardene, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.24135-7
Metadata
- Authors
- Appaiahgari, M. B., & Vrati, S.
- Affiliations
- Translational Health Science and Technology Institute (IN)
- Venue
- Expert Opinion on Biological Therapy
- Publisher
- Informa Healthcare
- Published
- 2014-12-22
- Volume
- 15
- Issue
- 3
- Pages
- 337-351
- ISSN
- 1471-2598 (ISSN-L)
- 1744-7682
- OpenAlex
- W2086054347
- Cited by
- 110
- References
- 97
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 11 · 2020: 11 · 2019: 13 · 2018: 14 · 2017: 12 · 2016: 16 · 2015: 7
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Biological Therapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- adenovirus, gene delivery vectors, vaccine vectors, gene therapy, adenovirus type 5, heterologous expression
- MeSH terms
- Adenoviridae, Animals, Genetic Vectors, Humans, Viral Vaccines, Genetic Therapy, Drug Delivery Systems, Gene Transfer Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review